XILIO THERAPEUTICS INC
COM · CUSIP 98422T100
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $7.07.
Trends to Q1 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2021 | 43 |
| Q1 2022 | 42 |
Biggest buyers
| STATE STREET CORP | Added | +34.7k |
| FMR LLC | Added | +20.5k |
| GEODE CAPITAL MANAGEMENT, LLC | Added | +7.5k |
| Bank of New York Mellon Corp | Added | +6.8k |
| Tower Research Capital LLC (TRC) | Added | +3.3k |
| BARCLAYS PLC | New | +1.2k |
| AMALGAMATED BANK | New | +1.1k |
| MORGAN STANLEY | Added | +1.1k |
| NORTHERN TRUST CORP | Added | +539 |
| NEW YORK STATE COMMON RETIREMENT FUND | Added | +64 |
Biggest sellers
| DEERFIELD MANAGEMENT COMPANY, L.P. | Reduced | -75.4k |
| Monashee Investment Management LLC | Reduced | -51.2k |
| CAAS CAPITAL MANAGEMENT LP | Sold out | -37.0k |
| Ghisallo Capital Management LLC | Sold out | -30.0k |
| BlackRock Inc. | Reduced | -24.3k |
| MARSHALL WACE, LLP | Sold out | -20.2k |
| VANGUARD GROUP INC | Reduced | -7.8k |
| JPMORGAN CHASE & CO | Reduced | -6.8k |
| UBS Group AG | Reduced | -3.0k |
| WELLS FARGO & COMPANY/MN | Reduced | -2.8k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| GILEAD SCIENCES, INC. 13G · passive investor no change · filed 2026-02-12 | 19.9% |
| Coastlands Capital LP 13G · institution new · filed 2025-12-11 | 10.0% |
| Sirenia Capital Management LP 13G · institution new · filed 2026-05-15 | 9.9% |
| AbbVie Inc. 13G · passive investor new · filed 2025-02-18 | 9.0% |
| Bain Capital Life Sciences Fund II, L.P. 13G · passive investor filed 2026-02-17 | 8.5% |
| STEMPOINT CAPITAL LP 13G · institution +1.2 pts · filed 2026-02-17 | 8.4% |
| Frazier Life Sciences Public Fund, L.P. 13G · passive investor -3.2 pts · filed 2026-02-13 | 6.7% |
Fell to 5% or below in the last year: Point72 Asset Management, L.P. (0.0%, 2026-05-15)
Holders, Q1 2022
| Manager | Shares | Change |
|---|---|---|
| Bain Capital Life Sciences Investors, LLC 1.93% of their portfolio | 2.8m $19.8m | Unchanged |
| Atlas Venture Life Science Advisors, LLC 2.47% of their portfolio | 2.8m $19.5m | Unchanged |
| FMR LLC 0.00% of their portfolio | 2.6m $18.3m | Added +20.5k |
| DEERFIELD MANAGEMENT COMPANY, L.P. 0.33% of their portfolio | 2.1m $14.7m | Reduced -75.4k |
| RA CAPITAL MANAGEMENT, L.P. 0.31% of their portfolio | 2.0m $14.2m | Unchanged |
| RiverVest Venture Management LLC 10.46% of their portfolio | 1.4m $10.2m | Unchanged |
| Rock Springs Capital Management LP 0.21% of their portfolio | 1.2m $8.4m | Unchanged |
| AJU IB Investment Co., Ltd. 7.29% of their portfolio | 667.7k $4.7m | Unchanged |
| Soleus Capital Management, L.P. 0.52% of their portfolio | 477.5k $3.4m | Unchanged |
| Artal Group S.A. 0.13% of their portfolio | 450.0k $3.2m | Unchanged |
| VANGUARD GROUP INC 0.00% of their portfolio | 416.4k $2.9m | Reduced -7.8k |
| HARVARD MANAGEMENT CO INC 0.30% of their portfolio | 416.1k $2.9m | Unchanged |
| NORGES BANK 0.00% of their portfolio | 400.0k $2.8m | Unchanged |
| BlackRock Inc. 0.00% of their portfolio | 299.8k $2.1m | Reduced -24.3k |
| FIL Ltd 0.00% of their portfolio | 218.7k $1.5m | Unchanged |
| Monashee Investment Management LLC 0.33% of their portfolio | 163.1k $1.2m | Reduced -51.2k |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 141.7k $1.0m | Added +7.5k |
| STATE STREET CORP 0.00% of their portfolio | 93.9k $664.0k | Added +34.7k |
| NORTHERN TRUST CORP 0.00% of their portfolio | 63.6k $449.0k | Added +539 |
| Bank of New York Mellon Corp 0.00% of their portfolio | 21.0k $149.0k | Added +6.8k |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.00% of their portfolio | 16.1k $114.0k | Unchanged |
| Nuveen Asset Management, LLC 0.00% of their portfolio | 11.3k $80.0k | Unchanged |
| Granite Point Capital Management, L.P. 0.04% of their portfolio | 10.0k $71.0k | Unchanged |
| NEW YORK STATE COMMON RETIREMENT FUND 0.00% of their portfolio | 5.6k $40.0k | Added +64 |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 4.8k $34.0k | Reduced -6.8k |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 4.3k $30.0k | Added +3.3k |
| DEUTSCHE BANK AG\ 0.00% of their portfolio | 4.0k $28.0k | Reduced -482 |
| AMERICAN INTERNATIONAL GROUP, INC. 0.00% of their portfolio | 3.8k $27.0k | Reduced -149 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 0.00% of their portfolio | 3.2k $23.0k | Reduced -870 |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 2.6k $19.0k | Reduced -2.2k |
| MORGAN STANLEY 0.00% of their portfolio | 2.1k $14.0k | Added +1.1k |
| STRS OHIO 0.00% of their portfolio | 1.7k $12.0k | Unchanged |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 1.7k $12.0k | Reduced -2.8k |
| BARCLAYS PLC 0.00% of their portfolio | 1.2k $8.0k | New |
| AMALGAMATED BANK 0.00% of their portfolio | 1.1k $8.0k | New |
| Amalgamated Financial Corp. 0.00% of their portfolio | 1.1k $8.0k | First filing |
| UBS Group AG 0.00% of their portfolio | 964 $7.0k | Reduced -3.0k |
| Legal & General Group Plc 0.00% of their portfolio | 698 $5.0k | Unchanged |
| Ameritas Investment Partners, Inc. 0.00% of their portfolio | 573 $4.0k | Unchanged |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 470 $3.0k | Reduced -1.1k |
| CITIGROUP INC 0.00% of their portfolio | 323 $2.0k | Reduced -1.9k |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |